The role of G-CSF in the treatment of advanced tumors

[1] Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice [J]. BONE MARROW TRANSPLANTATION, 2009, 43 (05) : 351 - 356

[2] Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (09) : 507 - 513

[3] Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of baldder cancer cells [J]. UROLOGY, 2007, 69 (06) : 1210 - 1215

[4] Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine plus FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 trial) [J]. CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4192 - 4199

[5] Second-line treatment of non-small cell lung cancer by biweekly gemcitabine and docetaxel plus /- granulocyte-macrophage colony stimulating factor and low dose aldesleukine [J]. CANCER BIOLOGY & THERAPY, 2009, 8 (06) : 497 - 502

[6] Sequential administration of GM-CSF (Sargramostim®) and IL-2 ± autologous vaccine as adjuvant therapy in cutaneous melanoma:: An interim report of a phase II clinical trial [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (03) : 285 - 291

[7] Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer [J]. ONCOLOGY, 2000, 59 (04) : 291 - 295

[8] Biochemotherapy in the treatment of metastatic melanoma in selected patients [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (06) : 382 - 386

[9] Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):

[10] Kidd PM, 2009, ALTERN MED REV, V14, P14

[1] Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice [J]. BONE MARROW TRANSPLANTATION, 2009, 43 (05) : 351 - 356

[2] Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (09) : 507 - 513

[3] Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of baldder cancer cells [J]. UROLOGY, 2007, 69 (06) : 1210 - 1215

[4] Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine plus FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 trial) [J]. CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4192 - 4199

[5] Second-line treatment of non-small cell lung cancer by biweekly gemcitabine and docetaxel plus /- granulocyte-macrophage colony stimulating factor and low dose aldesleukine [J]. CANCER BIOLOGY & THERAPY, 2009, 8 (06) : 497 - 502

[6] Sequential administration of GM-CSF (Sargramostim®) and IL-2 ± autologous vaccine as adjuvant therapy in cutaneous melanoma:: An interim report of a phase II clinical trial [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (03) : 285 - 291

[7] Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer [J]. ONCOLOGY, 2000, 59 (04) : 291 - 295

[8] Biochemotherapy in the treatment of metastatic melanoma in selected patients [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (06) : 382 - 386

[9] Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):

[10] Kidd PM, 2009, ALTERN MED REV, V14, P14